SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-075050
Filing Date
2022-06-28
Accepted
2022-06-28 09:46:23
Documents
13
Period of Report
2022-06-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2219550d1_8k.htm   iXBRL 8-K 25682
2 EXHIBIT 99.1 tm2219550d1_ex99-1.htm EX-99.1 16727
  Complete submission text file 0001104659-22-075050.txt   222596

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA hepa-20220627.xsd EX-101.SCH 3027
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE hepa-20220627_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hepa-20220627_pre.xml EX-101.PRE 22591
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2219550d1_8k_htm.xml XML 3583
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36856 | Film No.: 221046871
SIC: 2834 Pharmaceutical Preparations